CA Stock MarketDetailed Quotes

FH Filament Health Corp

Watchlist
  • 0.035
  • 0.0000.00%
15min DelayMarket Closed Oct 18 15:59 ET
9.16MMarket Cap-1750P/E (TTM)

Filament Health Corp Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
43.04%-482.54K
-24.27%-949.61K
-6.66%-4.19M
-69.48%-1.16M
-6.26%-1.41M
5.36%-847.15K
24.73%-764.16K
27.39%-3.93M
61.67%-687.33K
-714.32%-1.33M
Net income from continuing operations
32.27%-1.03M
27.66%-907.18K
67.68%-5.32M
89.83%-1.23M
-4.17%-1.31M
-3.74%-1.52M
21.36%-1.25M
-77.95%-16.47M
-412.44%-12.15M
24.17%-1.26M
Operating gains losses
-49.80%113.95K
52.63%63.45K
19.93%343.37K
----
----
--227.01K
298.26%41.57K
-78.74%286.31K
--307.28K
--0
Depreciation and amortization
4.52%53.7K
5.22%53.26K
4.06%208.8K
5.21%53.23K
6.99%53.57K
2.77%51.38K
1.25%50.62K
16.59%200.65K
1.94%50.59K
-4.27%50.07K
Asset impairment expenditure
----
----
--0
----
----
----
----
--10.87M
----
----
Remuneration paid in stock
----
----
----
----
----
----
----
----
----
-40.03%287.6K
Deferred tax
----
----
--0
--0
----
----
----
-86.87%-70.54K
---11.96K
----
Other non cashItems
-62.38%125.62K
-15.14%167.1K
-116.25%-157.69K
-147.66%-424.56K
-639.25%-263.93K
2,104.99%333.9K
1,147.87%196.9K
-66.30%970.63K
-30.47%890.76K
-96.87%48.95K
Change In working capital
301.59%255.82K
-262.54%-326.24K
163.29%739.92K
139.69%800.87K
18.42%-325.37K
-71.87%63.7K
68.29%200.72K
154.61%281.03K
-8.44%334.13K
-79.36%-398.83K
-Change in receivables
486.99%101.65K
842.24%63.3K
-685.77%-669.91K
-36,262.16%-317.08K
-941.97%-333.28K
39.27%-26.27K
173.49%6.72K
26.89%-85.26K
97.33%-872
-331.49%-31.99K
-Change in prepaid assets
-30.28%62.33K
-467.84%-76.61K
-71.46%114.77K
-89.29%18.38K
71.24%-13.83K
229.56%89.4K
-91.72%20.83K
162.21%402.17K
-12.69%171.59K
86.63%-48.08K
-Change in payables and accrued expense
15,954.37%91.83K
-280.70%-312.92K
3,256.26%1.13M
473.47%937.08K
106.82%21.74K
-99.76%572
240.65%173.17K
-114.44%-35.88K
-18.73%163.41K
-320.41%-318.76K
-Change in other working capital
----
----
--162.5K
----
----
----
----
----
----
----
Cash from discontinued investing activities
Operating cash flow
43.04%-482.54K
-24.27%-949.61K
-6.66%-4.19M
-69.48%-1.16M
-6.26%-1.41M
5.36%-847.15K
24.73%-764.16K
27.39%-3.93M
61.67%-687.33K
-714.32%-1.33M
Investing cash flow
Cash flow from continuing investing activities
-249.91%-16.86K
-71.30%-21.22K
18.64%-57.65K
-507.93%-62.54K
149.36%22.1K
-4.82K
21.61%-12.39K
73.34%-70.86K
-153.65%-10.29K
97.07%-44.77K
Net PPE purchase and sale
-249.91%-16.86K
-71.30%-21.22K
-79.29%-57.65K
73.88%-2.69K
-72.65%-37.76K
-130.49%-4.82K
21.61%-12.39K
75.35%-32.16K
51.04%-10.29K
-74.01%-21.87K
Net other investing changes
----
----
----
----
----
----
----
56.59%-38.7K
--0
----
Cash from discontinued investing activities
Investing cash flow
-249.91%-16.86K
-71.30%-21.22K
18.64%-57.65K
-507.93%-62.54K
149.36%22.1K
---4.82K
21.61%-12.39K
73.34%-70.86K
-153.65%-10.29K
97.07%-44.77K
Financing cash flow
Cash flow from continuing financing activities
3,463.22%962.99K
152.49%14.66K
45.71%3.23M
4,593.62%852.78K
28.03%2.43M
-111.98%-28.63K
-147.38%-27.93K
-76.50%2.21M
144.25%18.17K
2,523.37%1.9M
Net issuance payments of debt
-26.54%-36.23K
-26.54%-35.34K
-114.26%-123.25K
-84.68%2.78K
-107.32%-69.47K
53.11%-28.63K
31.98%-27.93K
1,002.27%864.44K
144.25%18.17K
3,746.94%948.39K
Net common stock issuance
----
----
167.98%3.35M
950.00%850K
163.16%2.5M
----
----
-87.50%1.25M
---100K
--949.98K
Proceeds from stock option exercised by employees
----
----
--0
----
----
----
----
55,455.56%100K
----
----
Net other financing activities
----
--50K
----
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
3,463.22%962.99K
152.49%14.66K
45.71%3.23M
4,593.62%852.78K
28.03%2.43M
-111.98%-28.63K
-147.38%-27.93K
-76.50%2.21M
144.25%18.17K
2,523.37%1.9M
Net cash flow
Beginning cash position
-57.30%872.05K
-35.78%1.83M
-38.50%2.85M
-37.53%2.2M
-61.29%1.16M
-44.16%2.04M
-38.50%2.85M
426.97%4.63M
-45.28%3.53M
-61.70%3M
Current changes in cash
152.64%463.59K
-18.86%-956.17K
42.85%-1.02M
44.86%-374.62K
98.23%1.04M
-34.22%-880.6K
17.24%-804.48K
-147.52%-1.78M
62.57%-679.44K
137.75%525.25K
End cash Position
14.98%1.34M
-57.30%872.05K
-35.78%1.83M
-35.78%1.83M
-37.53%2.2M
-61.29%1.16M
-44.16%2.04M
-38.50%2.85M
-38.50%2.85M
-45.28%3.53M
Free cash from
41.38%-499.4K
-25.02%-970.83K
-7.25%-4.25M
-67.36%-1.17M
-7.33%-1.45M
3.11%-851.97K
24.68%-776.55K
28.52%-3.96M
61.55%-697.61K
-762.97%-1.35M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 43.04%-482.54K-24.27%-949.61K-6.66%-4.19M-69.48%-1.16M-6.26%-1.41M5.36%-847.15K24.73%-764.16K27.39%-3.93M61.67%-687.33K-714.32%-1.33M
Net income from continuing operations 32.27%-1.03M27.66%-907.18K67.68%-5.32M89.83%-1.23M-4.17%-1.31M-3.74%-1.52M21.36%-1.25M-77.95%-16.47M-412.44%-12.15M24.17%-1.26M
Operating gains losses -49.80%113.95K52.63%63.45K19.93%343.37K----------227.01K298.26%41.57K-78.74%286.31K--307.28K--0
Depreciation and amortization 4.52%53.7K5.22%53.26K4.06%208.8K5.21%53.23K6.99%53.57K2.77%51.38K1.25%50.62K16.59%200.65K1.94%50.59K-4.27%50.07K
Asset impairment expenditure ----------0------------------10.87M--------
Remuneration paid in stock -------------------------------------40.03%287.6K
Deferred tax ----------0--0-------------86.87%-70.54K---11.96K----
Other non cashItems -62.38%125.62K-15.14%167.1K-116.25%-157.69K-147.66%-424.56K-639.25%-263.93K2,104.99%333.9K1,147.87%196.9K-66.30%970.63K-30.47%890.76K-96.87%48.95K
Change In working capital 301.59%255.82K-262.54%-326.24K163.29%739.92K139.69%800.87K18.42%-325.37K-71.87%63.7K68.29%200.72K154.61%281.03K-8.44%334.13K-79.36%-398.83K
-Change in receivables 486.99%101.65K842.24%63.3K-685.77%-669.91K-36,262.16%-317.08K-941.97%-333.28K39.27%-26.27K173.49%6.72K26.89%-85.26K97.33%-872-331.49%-31.99K
-Change in prepaid assets -30.28%62.33K-467.84%-76.61K-71.46%114.77K-89.29%18.38K71.24%-13.83K229.56%89.4K-91.72%20.83K162.21%402.17K-12.69%171.59K86.63%-48.08K
-Change in payables and accrued expense 15,954.37%91.83K-280.70%-312.92K3,256.26%1.13M473.47%937.08K106.82%21.74K-99.76%572240.65%173.17K-114.44%-35.88K-18.73%163.41K-320.41%-318.76K
-Change in other working capital ----------162.5K----------------------------
Cash from discontinued investing activities
Operating cash flow 43.04%-482.54K-24.27%-949.61K-6.66%-4.19M-69.48%-1.16M-6.26%-1.41M5.36%-847.15K24.73%-764.16K27.39%-3.93M61.67%-687.33K-714.32%-1.33M
Investing cash flow
Cash flow from continuing investing activities -249.91%-16.86K-71.30%-21.22K18.64%-57.65K-507.93%-62.54K149.36%22.1K-4.82K21.61%-12.39K73.34%-70.86K-153.65%-10.29K97.07%-44.77K
Net PPE purchase and sale -249.91%-16.86K-71.30%-21.22K-79.29%-57.65K73.88%-2.69K-72.65%-37.76K-130.49%-4.82K21.61%-12.39K75.35%-32.16K51.04%-10.29K-74.01%-21.87K
Net other investing changes ----------------------------56.59%-38.7K--0----
Cash from discontinued investing activities
Investing cash flow -249.91%-16.86K-71.30%-21.22K18.64%-57.65K-507.93%-62.54K149.36%22.1K---4.82K21.61%-12.39K73.34%-70.86K-153.65%-10.29K97.07%-44.77K
Financing cash flow
Cash flow from continuing financing activities 3,463.22%962.99K152.49%14.66K45.71%3.23M4,593.62%852.78K28.03%2.43M-111.98%-28.63K-147.38%-27.93K-76.50%2.21M144.25%18.17K2,523.37%1.9M
Net issuance payments of debt -26.54%-36.23K-26.54%-35.34K-114.26%-123.25K-84.68%2.78K-107.32%-69.47K53.11%-28.63K31.98%-27.93K1,002.27%864.44K144.25%18.17K3,746.94%948.39K
Net common stock issuance --------167.98%3.35M950.00%850K163.16%2.5M---------87.50%1.25M---100K--949.98K
Proceeds from stock option exercised by employees ----------0----------------55,455.56%100K--------
Net other financing activities ------50K--------------------------------
Cash from discontinued financing activities
Financing cash flow 3,463.22%962.99K152.49%14.66K45.71%3.23M4,593.62%852.78K28.03%2.43M-111.98%-28.63K-147.38%-27.93K-76.50%2.21M144.25%18.17K2,523.37%1.9M
Net cash flow
Beginning cash position -57.30%872.05K-35.78%1.83M-38.50%2.85M-37.53%2.2M-61.29%1.16M-44.16%2.04M-38.50%2.85M426.97%4.63M-45.28%3.53M-61.70%3M
Current changes in cash 152.64%463.59K-18.86%-956.17K42.85%-1.02M44.86%-374.62K98.23%1.04M-34.22%-880.6K17.24%-804.48K-147.52%-1.78M62.57%-679.44K137.75%525.25K
End cash Position 14.98%1.34M-57.30%872.05K-35.78%1.83M-35.78%1.83M-37.53%2.2M-61.29%1.16M-44.16%2.04M-38.50%2.85M-38.50%2.85M-45.28%3.53M
Free cash from 41.38%-499.4K-25.02%-970.83K-7.25%-4.25M-67.36%-1.17M-7.33%-1.45M3.11%-851.97K24.68%-776.55K28.52%-3.96M61.55%-697.61K-762.97%-1.35M
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data